Federal Register Notice: FDA’s Center for Veterinary Medicine has approved an original abbreviated new animal drug application filed by Cross Vetpharm Group Ltd. that provides for the veterinary prescription use of dexamethasone sodium phosphate injectable solution as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses. To view this notice, click here.
